| Symbol | BGM |
|---|---|
| Name | BGM GROUP LTD. |
| Sector | HEALTH CARE |
| Region | Asia |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | JIUQUAN ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE,GANSU PROVINCE, JIUQUAN, 735000, China |
| Telephone | +86 9372689523 |
| Fax | — |
| — | |
| Website | https://www.bgmgroupltd.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. Additional info from NASDAQ: |
New Form 3 - BGM Group Ltd. <b>Filed:</b> 2026-04-13 <b>AccNo:</b> 0002127728-26-000001 <b>Size:</b> 3 KB
Read more